Comprehensive Analysis of Worldwide Markets for Global Rosacea Treatment Market

Posted by Vakhas on April 29th, 2019

According to a report available on Grand View Research Inc, the worldwide rosacea treatment market is poised to rise to a valuation of USD 1.5 billion in 2017 and projected to exhibit a healthy CAGR of 6.8% during the forecast period (2019-2025). High disease prevalence, progressive formulations, and proactive government initiatives are likely to drive the market growth in the forthcoming period.

In addition, an unexpected rise in the availability of generic drugs and the increasing occurrence of rosacea is also likely to drive the market. However, increased penetration of generic drugs in the market and absence of appropriate treatment or cure is likely to hamper the market growth in the forecast period.

As per the National Rosacea Society, the disease affects approximately 415 million people across the globe. The over-all populace suffering from rosacea are predicted to be 2.5–5.5%. Inducing based on a predictable global population of 7.6 billion, yields 181,640,000 to 414,960,000 people suffering from rosacea all over the world.

As per the Canadian Dermatology Association, more than three million Canadians are affected from rosacea. Thus, the increasing number of people suffering from this disease is anticipated to drive the market growth in the forecast period.

In 2017, Food and Drug administration (FDA) permitted 1% Oxymetazoline Hydrochloride, (RHOFADE) cream for the topical therapy of persistent facial erythema related to rosacea in adults. It also approved tentative acceptance for Zenavod (doxycycline) capsules for the therapy of inflammatory lesions (pustules and papules) in adults.

North America will continue to account for a large share in the global arena throughout the forecast period due to new drug development, growing consumer awareness, and growing number of drug approvals for accurate diagnosis. Together, these are collectively propelling the regional development.

To Know More Information Of Rosacea Treatment Market @ https://www.grandviewresearch.com/industry-analysis/rosacea-treatment-market

Leading players operating in the rosacea treatment market include Bayer Schering AG; Allergan Plc; Nestlé S.A; Bausch Health Companies Inc.; Sol-Gel Technologies; and Foamix Pharmaceuticals. The leading companies are taking up mergers and acquisitions, and joint ventures and partnerships, in order to boost the inorganic growth of the industry.